Another study showed that 6-MP also inhibited progression of pulmonary hypertension, where NR4A1 induced bone morphogenic protein LCBMP signaling and decreased inflammation and proliferation in microvascular endothelial cells [125]. The gene discussed is NR4A1; the disease is pulmonary arterial hypertension.